论文部分内容阅读
联合王国,伦敦1999年9月讯:在对全球范围内可以预防失明的主要病因—粒性结膜炎(沙眼)的发生进行控制时,研究人员采用一种较短疗程的口服抗生素azithromycin(阿奇霉素)对全民进行治疗,其效果优于标准的6个星期为一疗程的日用四环素软膏的治疗效果。研究发现:儿童更易遭受可引致粒性结膜炎的沙眼衣原体的感染。该项研究的主要研究者Julius Schachter
London, United Kingdom, September, 1999: When controlling for the occurrence of granuloconjunctivitis (trachoma), the leading cause of preventable blindness worldwide, the researchers used a shorter course of oral azithromycin (azithromycin) The treatment of all people, the effect is better than the standard 6 weeks for a course of daily tetracycline ointment treatment. The study found that children are more susceptible to infection with Chlamydia trachomatis that can cause granuloconjunctivitis. Julius Schachter, principal investigator of the study